Good morning,
A warm welcome to new readers, and thank you to those who join us each week.
In today's edition:
- Barcelona backs PRBB Ciutadella with €104 million
- Cambridge Biomedical Campus secures £3 billion option
- Sutton approves £1 billion London Cancer Hub
- 🔒 Newcore closes £375 million UK social infrastructure fund
- 🔒 Kynda opens R&D and production site in Jelmstorf
- 🔒 Leverkusen office acquired for future medical use
- 🔒 Newdock leases healthcare logistics warehouse in Madrid
- 🔒 Plameca opens €11 million plant in Barcelona
- 🔒 Dublin's Mater Private plans major hospital expansion
- 🔒 Siemens Healthineers opens €10 million R&D centre in Dublin
- 🔒 NHS diagnostic centre delivered in Somerset
- 🔒 NHS medical centre in West London offered for sale
(🔒 = for paying members only. Subscribe here to unlock).
Enjoy today's newsletter,
— Stephen Ryan (connect with me on LinkedIn)
1. Barcelona backs PRBB Ciutadella with €104 million
In Q4 2025, the Government of Catalonia authorised €104 million to finance construction of the PRBB Ciutadella, a precision medicine research facility on the site of the old Mercat del Peix in Parc de la Ciutadella.
The investment comprises a €60 million loan from the Generalitat to the Barcelona Biomedical Research Park Consortium and €44 million from the Department of Research and Universities between 2025 and 2029.
The 24,700 sq m building will accommodate 800 researchers and 60 research groups from five Barcelona Institute of Science and Technology (BIST) centres.
It forms part of a three-building complex totalling 46,000 sq m. Architects are Barozzi Veiga.
2. Cambridge Biomedical Campus secures £3 billion option
Cambridgeshire County Council has granted Prologis an option to acquire 67 acres on a long leasehold basis for phases three and four of the Cambridge Biomedical Campus.
The partnership represents up to £3 billion of private investment over the next two decades and will deliver up to 2.4 million sq ft of life science research, development and innovation space, doubling the campus size.
Plans include an innovation hub with co-working laboratories, learning spaces, a skills centre, keyworker serviced apartments and offices for life science support companies.
The development is conditional on Prologis securing planning consent.
🔍 Need deeper insight into life sciences real estate?
In addition to this newsletter, we deliver bespoke research and strategic analysis for investors and developers — from acquisition support to market mapping and custom reporting.
Get in touch to discuss your next project.
3. Sutton approves £1 billion London Cancer Hub
Aviva Capital Partners and development manager Socius have secured planning approval from Sutton Council for a £1 billion expansion of the London Cancer Hub in Sutton.
The 12-acre project will deliver around 1 million sq ft (c. 92,900 sq m) of state-of-the-art laboratory and research space, including wet laboratories, pharmaceutical research and advanced manufacturing facilities, and flexible offices, together with approximately 220 affordable homes for key workers.
The professional team includes Gensler as architect and Arup as structural and building services engineer, with Aecom providing project management and cost consultancy services.
The wider district is already home to The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust’s Sutton campus.
👇 As a free member, you’re only seeing 3 of 12 deals this week.
Subscribers see them all so why not take a 14-day trial?
